Potential application of embryonic stem cells in Parkinson’s disease: drug screening and cell therapy

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.1, Iss.2, 2006-03, pp. : 175-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease

By Fricker-Gates Rosemary A Gates Monte A

Regenerative Medicine, Vol. 5, Iss. 2, 2010-03 ,pp. : 267-278

Future Medicine

Access to resources Recommend Favorite

Stem cell‐based therapy for Parkinson's disease

By Correia Ana Sofia Anisimov Sergey Li Jia Brundin Patrik

Annals of Medicine, Vol. 37, Iss. 7, 2005-11 ,pp. : 487-498

Informa Healthcare

Access to resources Recommend Favorite

Parthenogenetic embryonic stem cells with H19 siRNA-mediated knockdown as a potential resource for cell therapy

International Journal of Molecular Medicine, Vol. 29, Iss. 2, 2012-01 ,pp. : 257-262

Spandidos Publications

Access to resources Recommend Favorite

Human pluripotent stem cells for genetic disease modeling and drug screening

By Gauthier Morgane Maury Yves Peschanski Marc Martinat Cécile

Regenerative Medicine, Vol. 6, Iss. 5, 2011-09 ,pp. : 607-622

Future Medicine

Access to resources Recommend Favorite

Human embryonic stem cells as a model for embryotoxicity screening

By Krtolica Ana Ilic Dusko Genbacev Olga Miller Richard K

Regenerative Medicine, Vol. 4, Iss. 3, 2009-05 ,pp. : 449-459

Future Medicine

Access to resources Recommend Favorite